News in brief: Relapse rates around pregnancy in MS have improved; Women under represented in stroke trials; Parkinson medication link to colitis

MS relapse rates around pregnancy have improved High efficacy DMT continuation to, or beyond, conception in women with MS has markedly reduced relapse rates over the last ten years compared to historical cohorts. An Australian-led study of MS relapse in 1,619 women before, during and after pregnancy found the annualised relapse rate was 0.288 for ...

Already a member?

Login to keep reading.

© 2021 the limbic